Tromethamine

Tromethamine

SCHEMBL2263148

NC(CO)(CO)CO.NO

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DHFRGARTPTGFRPTGIRPTGS1PTGS2TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8envmurAthyA

The experimentally established mechanism targets of Tromethamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.91
LMNA P02545 1/20 0.91
KMT2A Q03164 1/20 0.91
KDM4E B2RXH2 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tromethamine SCHEMBL975 0.95
Tromethamine SCHEMBL3696191 0.95
Tromethamine SCHEMBL17484 0.95 MEN1 (1.00) MEN1LMNAKMT2AKDM4EPOLB
Tromethamine SCHEMBL9298764 0.91
Tromethamine SCHEMBL11847711 0.91
Tromethamine SCHEMBL2313359 0.91 MEN1 (0.91) MEN1LMNAKMT2AKDM4EPOLB
Tromethamine SCHEMBL2035496 0.91
Tromethamine SCHEMBL7091147 0.91
Tromethamine SCHEMBL7126002 0.91
Tromethamine SCHEMBL6063594 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4866140-A OIL, FUEL ADDITIVES EXXON CHEMICAL PATENTS INC. (US) 1989-09-12 US claimed
WO-2019177056-A1 MODIFIED PROTEIN, DRUG, PROPHYLACTIC OR THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE, AND METHOD FOR PRODUCING MODIFIED PROTEIN 国立大学法人北海道大学 2019-09-19 WO disclosed
WO-2019177053-A1 PROPHYLACTIC OR THERAPEUTIC AGENT FOR SYSTEMIC LUPUS ERYTHEMATOSUS OR DISEASES CAUSED BY SYSTEMIC LUPUS ERYTHEMATOSUS, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR CONNECTIVE TISSUE DISEASES 国立大学法人北海道大学 2019-09-19 WO disclosed
US-9492989-B2 Composition and method for manufacture of a fibrous polyurethane composite product HAUPT ROBERT A (US) 2016-11-15 US disclosed
US-20110189490-A1 COMPOSITION AND METHOD FOR MANUFACTURE OF A FIBROUS POLYURETHANE COMPOSITE PRODUCT HAUPT ROBERT A 2011-08-04 US disclosed